Tag: KRAS G12C

FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer

The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…

ME Desk

Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology

Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers…

ME Desk